Attached files

file filename
EX-10.6 - GRANT NOTICE FOR STOCK AWARD ISSUED DECEMBER 12, 2017 - Rafina Innovations Inc.ex106.htm
EX-10.4 - ADDENDUM NO. 3 TO THE CONSULTING AGREEMENT BETWEEN HCI VIOCARE AND SERGIOS KATSA - Rafina Innovations Inc.ex104.htm
EX-10.3 - GRANT NOTICE FOR STOCK AWARD ISSUED DECEMBER 12, 2017 - Rafina Innovations Inc.ex103.htm
EX-10.2 - CONSULTING AGREEMENT BETWEEN HCI VIOCARE AND PARASKEVI PILARINOU, DATED DECEMBER - Rafina Innovations Inc.ex102.htm
EX-10.1 - FORM OF PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT BETWEEN THE COMPANY AND THE IND - Rafina Innovations Inc.101.htm
8-K - 8-K - Rafina Innovations Inc.form8k.htm


Addendum No. 3

Dated December 11, 2017 to that certain agreement originally dated as of the 15th day of April 2014 by and between HCi Viocare, a Nevada corporation, with offices at Kintyre House, 209 Govan Road, Glasgow, Scotland, UK G51 1HJ (the "Company"), and Dr. Christos Kapatos, resident of 66 Stewarton Drive, Cambuslang, Glasgow G72 8DG, Scotland, UK (the "Advisor"), hereinafter referred to as the "Agreement".

The Section 2. Term; Subsection 2.1 Term of that certain Agreement is amended as follows:

"The term of this Agreement (the "Term") shall be from and including April 15, 2014, to and including April 15, 2018, unless this Agreement is earlier terminated in accordance with Section 5".

This Addendum No. 3 shall enure to the benefit of and be binding upon the parties hereto and their respective assigns, successors and personal representative(s).
 
The terms and conditions and provisions as contained in the Agreement remain in full force and effect.
 
This Addendum No. 3 shall be appended to and form a part of the Agreement.
 
IN WITNESS WHEREOF the parties hereto have caused this Addendum No. 3 to be duly executed and delivered as of the day and year first written above.


 
The Company 
/s/Sotirios Leontaritis 
HCi Viocare
By its President
Sotirios Leontaritis
 
The Advisor
/s/Dr. Christos Kapatos 
Dr. Christos Kapatos